Sinequan and Sustiva (Efavirenz Capsules)
Determining the interaction of Sinequan and Sustiva (Efavirenz Capsules) and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using efavirenz together with doxepin can increase the risk of an irregular heart rhythm that may be serious and potentially life-threatening, although it is a relatively rare side effect. You may be more susceptible if you have a heart condition called congenital long QT syndrome, other cardiac diseases, conduction abnormalities, or electrolyte disturbances (for example, magnesium or potassium loss due to severe or prolonged diarrhea or vomiting). Talk to your doctor if you have any questions or concerns. Your doctor may already be aware of the risks, but has determined that this is the best course of treatment for you and has taken appropriate precautions and is monitoring you closely for any potential complications. You should seek immediate medical attention if you develop sudden dizziness, lightheadedness, fainting, shortness of breath, or heart palpitations during treatment with these medications, whether together or alone. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:GENERALLY AVOID: Efavirenz can cause significant QT interval prolongation in patients with the CYP450 2B6 *6/*6 genotype due to reduced metabolic clearance of the drug stemming from decreased levels of functional CYP450 2B6 isoenzyme. Theoretically, coadministration with other agents that can prolong the QT interval may result in additive effects and increased risk of ventricular arrhythmias including torsade de pointes and sudden death. In a QT study conducted in 58 healthy subjects enriched for CYP450 2B6 polymorphisms, mean efavirenz peak plasma concentration (Cmax) in subjects with the CYP450 2B6 *6/*6 genotype was 2.25-fold that observed in subjects with the CYP450 2B6 *1/*1 genotype following administration of efavirenz 600 mg daily for 14 days. A positive relationship between efavirenz concentration and QTc prolongation was observed, with mean QTc prolongation and its upper bound 90% confidence interval at 8.7 ms and 11.3 ms in subjects with the CYP450 2B6 *6/*6 genotype. In general, the risk of an individual agent or a combination of agents causing ventricular arrhythmia in association with QT prolongation is largely unpredictable but may be increased by certain underlying risk factors such as congenital long QT syndrome, cardiac disease, and electrolyte disturbances (e.g., hypokalemia, hypomagnesemia). In addition, the extent of drug-induced QT prolongation is dependent on the particular drug(s) involved and dosage(s) of the drug(s).
MANAGEMENT: Alternatives to efavirenz should be considered in patients receiving other drugs that can prolong the QT interval. Patients treated with any medication that can cause QT prolongation should be advised to seek prompt medical attention if they experience symptoms that could indicate the occurrence of torsade de pointes such as dizziness, lightheadedness, fainting, palpitation, irregular heart rhythm, shortness of breath, or syncope.
- "Product Information. Sustiva (efavirenz)." DuPont Pharmaceuticals, Wilmington, DE.
Generic Name: doxepin
Brand name: Sinequan, Sinequan, Silenor
Synonyms: Sinequan Capsules
Generic Name: efavirenz
Brand name: Sustiva
Synonyms: Sustiva
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Sinequan-Sustiva (Efavirenz Tablets)
- Sinequan-Sustol
- Sinequan-Sustol injection
- Sinequan-SuTan
- Sinequan-SuTan-DM
- Sinequan-Sutent
- Sustiva (Efavirenz Capsules)-Sinequan (Doxepin Capsules)
- Sustiva (Efavirenz Capsules)-Sinequan (Doxepin Oral Concentrate)
- Sustiva (Efavirenz Capsules)-Sinex Long-Acting
- Sustiva (Efavirenz Capsules)-Sinex Nasal Spray
- Sustiva (Efavirenz Capsules)-Singulair
- Sustiva (Efavirenz Capsules)-Singulair (Montelukast Chewable Tablets)